MedTrace Logo

Biology and Experience of Eating in Women With Obesity

NCT02805972 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2021-11-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to understand how the opioid system is involved in eating behavior.

Conditions

Interventions

DRUG

Naloxone

4 mg / 0.1 ml

DRUG

Placebo

0.1 ml

Sponsors & Collaborators

Principal Investigators

  • Ashley E Mason, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-20
Primary Completion
2018-07-25
Completion
2018-07-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02805972 on ClinicalTrials.gov